Compounded · §503A · Per-patient preparation
Weekly compounded tirzepatide injection
A weekly subcutaneous dual GIP / GLP-1 injection, prepared on a per-patient basis by a US-licensed compounding pharmacy when a licensed clinician determines it is the right fit for your care.
- Once-weekly subcutaneous injection
- Compounded dual GIP / GLP-1 prepared per-patient under §503A
- Shipped from a US-licensed compounding pharmacy in discreet packaging
- Flat $359/month — no insurance routing
Cash-pay price
$359/mo
Cash-pay only; not billed to insurance. Eligibility determined by a US-licensed clinician.
About
What is Tirzepatide injection?
Tirzepatide is a dual-action molecule that activates both the GIP and GLP-1 receptors. In compounded form, it's prepared by a US-licensed compounding pharmacy on a per-patient basis under §503A of the Federal Food, Drug, and Cosmetic Act, when a licensed clinician determines that a commercially available, FDA-approved product is not clinically appropriate for the specific patient.
Per-patient compounding · §503A
Compounded tirzepatide is prepared on a per-patient basis when a licensed clinician documents a clinical difference between your needs and the commercially available, FDA-approved products — for example, a dose strength that isn't commercially manufactured.
Dosing
Dosing & schedule
Your clinician sets a personalized titration schedule based on your history and how you tolerate the medication. The general pattern starts low and increases every 4 weeks as tolerated.
- Weeks 1–4Lowest starting dose — set by your clinician
- Weeks 5–8First escalation if well-tolerated
- Weeks 9+Maintenance dose individualized by your clinician
How it works
01
Complete your online intake
A short, clinical questionnaire — about 5 minutes. Honest answers help your clinician give the best recommendation.
02
A US-licensed clinician reviews
A licensed clinician in your state reviews your intake and decides whether a prescription is clinically appropriate. They may message you for follow-up if needed.
03
Ships from a US-licensed pharmacy
If approved, your prescription is dispensed by a US-licensed pharmacy and shipped to your door in discreet packaging.
Safety
Important safety information
GLP-1 medications can cause nausea, vomiting, diarrhea, constipation, and abdominal discomfort, particularly during dose increases. Rare but serious risks include pancreatitis, gallbladder disease, kidney injury from dehydration, and — based on animal studies — a possible risk of thyroid C-cell tumors. Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use these medications. Always disclose your full medical history to your clinician.
Compounded preparations are not FDA-approved, are not generic versions of any brand-name GLP-1 medication, and have not been evaluated by the FDA for safety, efficacy, or quality. Outcomes from the pivotal clinical trials of FDA-approved Wegovy®, Ozempic®, Zepbound®, or Mounjaro® have not been clinically established for compounded preparations.
FAQ
Common questions
No. Compounded tirzepatide is not the same as Zepbound® or Mounjaro® and is not a generic version of them. It is prepared by a US-licensed compounding pharmacy on a per-patient basis when a licensed clinician determines a commercially available, FDA-approved product is not clinically appropriate for the specific patient.
Tirzepatide is a dual GIP and GLP-1 receptor agonist, while semaglutide is a GLP-1 receptor agonist. Your clinician can discuss the difference in mechanism and what might be more appropriate for your specific situation.
The standard compounded tirzepatide injection is $359/month, or $927 quarterly. Pricing is flat with no insurance routing. The quarterly bundle saves $150 vs. paying month-to-month.
No. Pallas is a cash-pay service. Insurance is not currently billed for any medication on the platform. Pricing is flat and disclosed up front — what you see is what you pay.
Complete a short clinical intake — usually under 5 minutes. A US-licensed clinician reviews your history, decides whether a prescription is clinically appropriate, and (if approved) sends it to a US-licensed pharmacy that ships directly to you in discreet packaging.
Yes. There is no long-term contract. You can pause or cancel your subscription at any time from your patient portal. Refunds are handled on a case-by-case basis per our terms.
Start your visit
